Today's Daily Dose brings you news about ACADIA's CLARITY trial results; Clovis' lackluster third quarter financial results; CryoLife's revised earnings and revenue outlook for the year; FDA approval of the third Humira biosimilar, and Strongbridge's deal with Novo Nordisk.
from RTT - Biotech https://ift.tt/2zgC17r
via IFTTT
No comments:
Post a Comment